Recent Finacing
Recent Raise
AZTherapies is a clinical-stage biopharma developing small-molecule and biologic therapies for neurodegenerative diseases, advancing ALZT‑OP1 in Phase 3 pivotal trial and programs for ALS, post-stroke cognitive impairment, CAR‑Treg.
